Whether Martin’s Point covers weight loss medication depends on which plan you have. Generations Advantage, the Medicare Advantage line, does not cover drugs prescribed specifically for weight loss. The US Family Health Plan, Martin’s Point’s TRICARE Prime option, does cover them with prior authorization. And starting July 1, 2026, a new federal demonstration gives most Medicare members a separate $50-copay path to Wegovy, Zepbound, and Foundayo regardless of what their Part D plan covers.
Generations Advantage Does Not Cover Weight Loss Drugs
Martin’s Point’s Medicare Advantage plans classify medications used for weight loss or weight gain as excluded from Part D coverage. The plan names Zepbound, Contrave, phentermine, and Saxenda as examples.1Martin’s Point Health Care. Have a New Prescription
That exclusion comes from federal law. Medicare Part D has long prohibited coverage of drugs used solely for weight loss. CMS considered reinterpreting the rule for 2026 but did not finalize the proposal, so the prohibition stands.2Sheppard Mullin. CMS Issues CY 2026 Medicare Advantage and Part D Final Rule
Wegovy and Zepbound: Non-Formulary
Both Wegovy (semaglutide) and Zepbound (tirzepatide) sit on the 2026 Generations Advantage formulary as “non-formulary medical exception” drugs. They are not automatically covered for any use, including weight loss. A provider has to submit a non-formulary medical exception request and show the drug is being prescribed for a medically accepted indication other than weight management.3Martin’s Point Health Care. Quick Reference Guide – 2026 GLP-1 Coverage
CMS does let Medicare plans cover obesity drugs when the FDA has approved them for another purpose, such as reducing the risk of major cardiovascular events. Wegovy carries that kind of approval. Even so, Martin’s Point treats it as non-formulary. The exception request has to explain why formulary alternatives won’t work, document treatment failures or adverse reactions, and give clinical rationale for choosing Wegovy over covered options.3Martin’s Point Health Care. Quick Reference Guide – 2026 GLP-1 Coverage No patient assistance program is available through the plan.
Ozempic and Mounjaro Are Covered Only for Diabetes
Ozempic (semaglutide) and Mounjaro (tirzepatide) are on the formulary at Tier 3, with a 25% cost share. Coverage is tied to Type 2 diabetes. Ozempic is also approved for reducing cardiovascular risk and slowing chronic kidney disease progression in diabetic patients. Mounjaro is covered only for glycemic control in Type 2 diabetes.3Martin’s Point Health Care. Quick Reference Guide – 2026 GLP-1 Coverage
Neither drug needs prior authorization if the prescription carries an ICD-10 code for Type 2 diabetes or the patient has used an antidiabetic medication (other than another GLP-1) within the past two years. Neither is covered for prediabetes or weight management by itself.3Martin’s Point Health Care. Quick Reference Guide – 2026 GLP-1 Coverage
The Medicare GLP-1 Bridge Program Starts July 2026
From July 1, 2026 through at least December 31, 2026, a federal demonstration called the Medicare GLP-1 Bridge gives Medicare beneficiaries, including Generations Advantage members, a separate route to weight loss drugs. The program covers Wegovy, Zepbound, and Foundayo for weight reduction.4Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge
The Bridge operates outside Martin’s Point’s Part D benefit. CMS has appointed Humana as the central processor for prior authorization, claims, and pharmacy payments. Providers send requests to that central processor, not to Martin’s Point, and Martin’s Point does not need to opt in for its members to use the program.4Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge5Medicare Rights Center. GLP-1 Weight Loss Drug Demonstration Begins July 2026 Beneficiaries pay a flat $50 copay per prescription, and that amount does not count toward Part D deductibles or out-of-pocket maximums.6KFF. What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid
Who Qualifies
You must be enrolled in an eligible Part D plan, be 18 or older, and meet BMI-based clinical criteria when therapy starts:
- BMI of 35 or higher, with no additional diagnosis required.
- BMI of 30 or higher with heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease (stage 3a or above).
- BMI of 27 or higher with pre-diabetes, a history of heart attack, a history of stroke, or symptomatic peripheral artery disease.
Treatment has to include ongoing lifestyle modifications such as structured nutrition and physical activity. If you have Type 2 diabetes, obstructive sleep apnea, or MASH, you are not eligible for the Bridge because those conditions already have coverage pathways under standard Part D, and providers should use Martin’s Point’s formulary exception process instead.7Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge – Information for Providers
US Family Health Plan: Weight Loss Drugs Are Covered
Martin’s Point administers the US Family Health Plan, a TRICARE Prime option for military families, retirees, and their dependents. This plan does cover weight loss medications, including GLP-1 drugs approved specifically for that use.8Martin’s Point Health Care. GLP-1 Medication Coverage9TRICARE. Weight Loss Products
The preferred weight management drugs are Wegovy and Zepbound. Saxenda (liraglutide) is also covered. All require prior authorization. Older non-GLP-1 options including phentermine, Contrave, Qsymia, and Lomaira have their own prior authorization pathways as well.8Martin’s Point Health Care. GLP-1 Medication Coverage10US Family Health Plan. Prior Authorization Forms
Prior Authorization for Wegovy and Zepbound
Initial approval runs 12 months and renews annually. For adults 18 and older, a provider has to document:
- A BMI of 30 or higher, or a BMI of 27 to 29 with at least one weight-related comorbidity such as hypertension, dyslipidemia, obstructive sleep apnea, metabolic syndrome, diabetes, or established cardiovascular disease.
- At least six months of participation in a behavioral modification and dietary program (nutritional counseling, diet tracking apps, or structured weight loss programs qualify), with failure to achieve the desired weight loss.
- A three-month trial of generic phentermine, benzphetamine, diethylpropion, or phendimetrazine without achieving a 5% reduction in baseline weight, or a documented contraindication or adverse reaction to those drugs.
For adolescents aged 12 to 17, only Wegovy is covered. BMI must sit at or above the 95th percentile for age and sex, and six months of documented dietary and behavioral engagement is required. Zepbound is not covered in this age group.11Martin’s Point Health Care. Wegovy-Zepbound Prior Authorization Form
Zepbound also has a separate indication for obstructive sleep apnea in adults with a BMI of 30 or higher and a documented apnea-hypopnea index of 15 or more events per hour.11Martin’s Point Health Care. Wegovy-Zepbound Prior Authorization Form
Renewing After the First Year
Adults have to show at least a 5% loss of baseline body weight to renew. Adolescents need at least a 4% loss. Everyone has to show continued engagement in behavioral modification and a reduced-calorie diet, with documentation in the medical record.11Martin’s Point Health Care. Wegovy-Zepbound Prior Authorization Form
Saxenda
Saxenda follows a different path. Initial approval lasts six months rather than 12. The step therapy requirement is wider: patients must have tried and failed, or have a contraindication to, phentermine, Qsymia, Contrave, metformin, and preferred GLP-1 receptor agonists like Trulicity. Renewal requires at least a 4% loss of baseline body weight after 16 weeks and a 5% reduction in baseline BMI.12US Family Health Plan. Saxenda Wegovy Zepbound Prior Authorization Form
Cost and Where to Fill It
Members can fill GLP-1 weight management prescriptions through the Martin’s Point Mail-Order Pharmacy for up to a 60-day supply with a single copay. Retail pharmacies are limited to a 30-day supply. Diabetes GLP-1s can go up to 90 days by mail.8Martin’s Point Health Care. GLP-1 Medication Coverage
Under 2026 TRICARE pharmacy copays, home delivery runs $14 for generics, $44 for brand-name drugs, and $85 for non-formulary drugs (up to a 90-day supply). Retail network copays for a 30-day supply are $16, $48, and $85.13Express Scripts. Changes to Your TRICARE Prescription Drug Copayments 2026 The actual copay for Wegovy or Zepbound depends on each drug’s formulary tier, which members can confirm through the Express Scripts Formulary Search Tool.14Martin’s Point Health Care. Drug Formularies
Wellness Benefits That Help With Weight Management
Generations Advantage members on the Prime HMO-POS or Select PPO plans get a Wellness Wallet with an annual allowance of up to $300. Alliance HMO members get $425. Eligible expenses include gym memberships, fitness classes, personal trainers, activity trackers like Fitbit or Apple Watch, home exercise equipment, and subscriptions to Weight Watchers or Noom. Food costs are not covered.15Martin’s Point Health Care. Wellness Wallet16Martin’s Point Health Care. Wellness Wallet Items
US Family Health Plan members have WholeHealth Living Choices, a discount program offering 10 to 30% off services including nutritional counseling, acupuncture, massage, and yoga. The plan also offers a free care management program that pairs members with a dedicated care manager who can help coordinate weight-related health goals and medication questions.17Martin’s Point Health Care. Wellness Discounts